Table 3

Demographics of matched cohort and comparison of outcomes

VariableMatched ICE casesMatched no ICE controlsP-valuea
(n = 139)(n = 139)
Age (years)15 [12–17]15.1 [13.1–16.8]0.66
Female53 (38.1)69 (49.6)0.05
Non-white19 (13.7)13 (9.4)0.26
Weight (kg)56.8 [48.2–71.3]57.0 [46.3–71.4]0.60
BSA (m2)1.6 [1.4–1.8]1.6 [1.4–1.8]0.61
CHD19 (13.7)19 (13.7)
 Biventricular CHD Ebstein7 (5.0)7 (5.0)
 Anomaly2 (1.4)2 (1.4)
 Fontan circulation5 (3.6)5 (3.6)
 Intracardiac baffle5 (3.6)5 (3.6)
Arrhythmia mechanismb
 AVRT81 (58.3)81 (58.3)
 AVNRT34 (24.5)34 (24.5)
 IART19 (13.7)19 (13.7)
 EAT3 (2.2)3 (2.2)
 PVCs/VT3 (2.2)3 (2.2)
Pre-excitation43 (30.1)43 (30.1)
Arrhythmia site
 Right64 (46.0)64 (46.0)
 Left62 (44.6)62 (44.6)
 >1 ablation site5 (3.6)5 (3.6)
 Trans-bafflec8 (5.8)8 (5.8)
Acute procedural success139 (100)135 (97.1)0.12
Complications2d (1.4)0 (0)1.0
Fluoroscopy exposure (min)0.3 [0.1–3.5]2.1 [0.2–4.1]0.02
Procedural time (min)141 [118.5–182]173 [124–219.5]0.01
Arrhythmia recurrencee9 (6.5)23 (16.5)0.01
VariableMatched ICE casesMatched no ICE controlsP-valuea
(n = 139)(n = 139)
Age (years)15 [12–17]15.1 [13.1–16.8]0.66
Female53 (38.1)69 (49.6)0.05
Non-white19 (13.7)13 (9.4)0.26
Weight (kg)56.8 [48.2–71.3]57.0 [46.3–71.4]0.60
BSA (m2)1.6 [1.4–1.8]1.6 [1.4–1.8]0.61
CHD19 (13.7)19 (13.7)
 Biventricular CHD Ebstein7 (5.0)7 (5.0)
 Anomaly2 (1.4)2 (1.4)
 Fontan circulation5 (3.6)5 (3.6)
 Intracardiac baffle5 (3.6)5 (3.6)
Arrhythmia mechanismb
 AVRT81 (58.3)81 (58.3)
 AVNRT34 (24.5)34 (24.5)
 IART19 (13.7)19 (13.7)
 EAT3 (2.2)3 (2.2)
 PVCs/VT3 (2.2)3 (2.2)
Pre-excitation43 (30.1)43 (30.1)
Arrhythmia site
 Right64 (46.0)64 (46.0)
 Left62 (44.6)62 (44.6)
 >1 ablation site5 (3.6)5 (3.6)
 Trans-bafflec8 (5.8)8 (5.8)
Acute procedural success139 (100)135 (97.1)0.12
Complications2d (1.4)0 (0)1.0
Fluoroscopy exposure (min)0.3 [0.1–3.5]2.1 [0.2–4.1]0.02
Procedural time (min)141 [118.5–182]173 [124–219.5]0.01
Arrhythmia recurrencee9 (6.5)23 (16.5)0.01

Values are presented as median [interquartile range] or n (%).

AVNRT, atrioventricular nodal re-entrant tachycardia; AVRT, atrioventricular re-entrant tachycardia; BSA, body surface area; EAT, ectopic atrial tachycardia; IART, intra-atrial re-entrant tachycardia; ICE, intracardiac echocardiography; IQR, interquartile range; PVCs/VT, premature ventricular complexes/ventricular tachycardia.

aMatched variable P-values are 1.0 and not elsewhere reported.

bSome patients had multiple arrhythmia mechanisms.

cTrans-baffle approach included Fontan and intracardiac baffles in biventricular palliations.

dTransseptal needle entry into pericardial space during first transseptal attempt (without ICE). One case with atrial flutter that degenerated into ventricular fibrillation arrest, requiring compressions; not related to ICE usage.

eFor the purposes of arrhythmia recurrence, only patients undergoing successful ablation were considered.

Table 3

Demographics of matched cohort and comparison of outcomes

VariableMatched ICE casesMatched no ICE controlsP-valuea
(n = 139)(n = 139)
Age (years)15 [12–17]15.1 [13.1–16.8]0.66
Female53 (38.1)69 (49.6)0.05
Non-white19 (13.7)13 (9.4)0.26
Weight (kg)56.8 [48.2–71.3]57.0 [46.3–71.4]0.60
BSA (m2)1.6 [1.4–1.8]1.6 [1.4–1.8]0.61
CHD19 (13.7)19 (13.7)
 Biventricular CHD Ebstein7 (5.0)7 (5.0)
 Anomaly2 (1.4)2 (1.4)
 Fontan circulation5 (3.6)5 (3.6)
 Intracardiac baffle5 (3.6)5 (3.6)
Arrhythmia mechanismb
 AVRT81 (58.3)81 (58.3)
 AVNRT34 (24.5)34 (24.5)
 IART19 (13.7)19 (13.7)
 EAT3 (2.2)3 (2.2)
 PVCs/VT3 (2.2)3 (2.2)
Pre-excitation43 (30.1)43 (30.1)
Arrhythmia site
 Right64 (46.0)64 (46.0)
 Left62 (44.6)62 (44.6)
 >1 ablation site5 (3.6)5 (3.6)
 Trans-bafflec8 (5.8)8 (5.8)
Acute procedural success139 (100)135 (97.1)0.12
Complications2d (1.4)0 (0)1.0
Fluoroscopy exposure (min)0.3 [0.1–3.5]2.1 [0.2–4.1]0.02
Procedural time (min)141 [118.5–182]173 [124–219.5]0.01
Arrhythmia recurrencee9 (6.5)23 (16.5)0.01
VariableMatched ICE casesMatched no ICE controlsP-valuea
(n = 139)(n = 139)
Age (years)15 [12–17]15.1 [13.1–16.8]0.66
Female53 (38.1)69 (49.6)0.05
Non-white19 (13.7)13 (9.4)0.26
Weight (kg)56.8 [48.2–71.3]57.0 [46.3–71.4]0.60
BSA (m2)1.6 [1.4–1.8]1.6 [1.4–1.8]0.61
CHD19 (13.7)19 (13.7)
 Biventricular CHD Ebstein7 (5.0)7 (5.0)
 Anomaly2 (1.4)2 (1.4)
 Fontan circulation5 (3.6)5 (3.6)
 Intracardiac baffle5 (3.6)5 (3.6)
Arrhythmia mechanismb
 AVRT81 (58.3)81 (58.3)
 AVNRT34 (24.5)34 (24.5)
 IART19 (13.7)19 (13.7)
 EAT3 (2.2)3 (2.2)
 PVCs/VT3 (2.2)3 (2.2)
Pre-excitation43 (30.1)43 (30.1)
Arrhythmia site
 Right64 (46.0)64 (46.0)
 Left62 (44.6)62 (44.6)
 >1 ablation site5 (3.6)5 (3.6)
 Trans-bafflec8 (5.8)8 (5.8)
Acute procedural success139 (100)135 (97.1)0.12
Complications2d (1.4)0 (0)1.0
Fluoroscopy exposure (min)0.3 [0.1–3.5]2.1 [0.2–4.1]0.02
Procedural time (min)141 [118.5–182]173 [124–219.5]0.01
Arrhythmia recurrencee9 (6.5)23 (16.5)0.01

Values are presented as median [interquartile range] or n (%).

AVNRT, atrioventricular nodal re-entrant tachycardia; AVRT, atrioventricular re-entrant tachycardia; BSA, body surface area; EAT, ectopic atrial tachycardia; IART, intra-atrial re-entrant tachycardia; ICE, intracardiac echocardiography; IQR, interquartile range; PVCs/VT, premature ventricular complexes/ventricular tachycardia.

aMatched variable P-values are 1.0 and not elsewhere reported.

bSome patients had multiple arrhythmia mechanisms.

cTrans-baffle approach included Fontan and intracardiac baffles in biventricular palliations.

dTransseptal needle entry into pericardial space during first transseptal attempt (without ICE). One case with atrial flutter that degenerated into ventricular fibrillation arrest, requiring compressions; not related to ICE usage.

eFor the purposes of arrhythmia recurrence, only patients undergoing successful ablation were considered.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close